Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06543849
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-01
Brief Title:
The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
The Impact of Targeted Temperature Management Duration on Thrombin Function in Cardiac Arrest Patients ITTC Trial A Single-Center Prospective Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ITTC
Brief Summary:
This study will be a single-center prospective randomized controlled trial with an estimated sample size of 64 patients Eligible patients will be randomly assigned in a 11 ratio to receive TTM for either 24 hours or 72 hours The primary outcome measure will be the changes in thrombin function indices at various time points during TTM treatment in both groups The secondary endpoints of the study include additional coagulation function indicators the incidence of bleeding-related events between the two groups the amount of blood products used the incidence of thrombotic events and the CPC scores at 28 days and 6 months for both groups
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None